Axa S.A. Iovance Biotherapeutics, Inc. Transaction History

Axa S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $478,789 - $878,253	-16,700 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $691,134 - $1.04 Million	-25,400 Reduced 60.33%	16,700 $458,000
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $822,634 - $1.64 Million	42,100 New	42,100 $1.26 Million
Q1 2019 May 14, 2019	SELL	$8.41 - $11.26 $721,535 - $966,051	-85,795 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$7.51 - $11.93 $130,674 - $207,582	-17,400 Reduced 16.86%	85,795 $759,000
Q2 2018 Aug 13, 2018	BUY	$12.45 - $16.95 $230,225 - $313,439	18,492 Added 21.83%	103,195 $1.32 Million
Q1 2018 May 14, 2018	SELL	$8.1 - $19.5 $4.73 Million - $11.4 Million	-584,272 Reduced 87.34%	84,703 $1.43 Million
Q4 2017 Feb 13, 2018	SELL	$6.65 - $9.25 $4,069 - $5,661	-612 Reduced 0.09%	668,975 $5.35 Million
Q3 2017 Nov 13, 2017	BUY	$4.45 - $8.55 $2.98 Million - $5.72 Million	669,587	669,587 $5.19 Million

319

243M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $923M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.